MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bph.70198

Медицинская библиотека · British journal of pharmacology · 2025

Nuclear factor, erythroid 2 like 2 (NRF2)-mediated disruption of iron homeostasis drives myocardial infarction progression.

Jayakumar Deepthy, S Narasimhan Kishore Kumar, Chandrasekar Navvi, Rajkumar Abinayaa, Panchalingam Gokulprasanth, Ravikumar Varsha C, Periandavan Kalaiselvi

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND PURPOSE: Disruptions in iron homeostasis are a hallmark of myocardial infarction (MI). Recent studies have implicated NRF2, a key transcriptional regulator of antioxidant and detoxification genes, in the regulation of iron metabolism, particularly in murine models of hepatic iron overload. Emerging evidence suggests that the NRF2/hepcidin/ferroportin axis plays a central role in co-ordinating cardiac iron and redox homeostasis. However, the underlying mechanisms remain poorly understood.

EXPERIMENTAL APPROACH: In this study, we investigated the role of NRF2 in vivo using isoprenaline-induced MI and in vitro under cobalt chloride (CoCl₂)-induced hypoxia in H9c2 cardiomyocytes.

KEY

RESULTS

Our results show that MI activates NRF2 signalling through increased nuclear NRF2 levels and upregulation of its downstream targets, accompanied by elevated hepcidin expression without ferroportin1 (IREG1) changes, suggesting enhanced iron sequestration in myocardial tissue and cardiomyocytes. We observed that iron regulatory protein 1 (IRP1) was significantly down-regulated while IRP2 was up-regulated in isoprenaline-treated myocardium and hypoxia-exposed H9c2 cells. In vivo brusatol administration ameliorated isoprenaline-induced cardiac remodelling, shown by reduced infarct size and ECG alterations. Transcriptomic analysis of MI rats with brusatol showed downregulation of pathways in cardiac remodelling, fibrosis, hypoxia, inflammation, iron/glutathione metabolism, necroptosis and ferroptosis. In H9c2 cardiomyocytes under hypoxic conditions, brusatol increased ferroportin1 expression, decreased hepcidin levels and reduced intracellular labile iron, inhibiting ferritinophagy and cardiomyocyte death.

CONCLUSION

Together, our findings uncover a novel regulatory role for NRF2 in myocardial iron metabolism under stress conditions, highlighting potential therapeutic avenues targeting the NRF2 pathway in MI.

Для цитирования: Jayakumar Deepthy, S Narasimhan Kishore Kumar, Chandrasekar Navvi, Rajkumar Abinayaa, Panchalingam Gokulprasanth, Ravikumar Varsha C, Periandavan Kalaiselvi. Nuclear factor, erythroid 2 like 2 (NRF2)-mediated disruption of iron homeostasis drives myocardial infarction progression.. British journal of pharmacology. 2025. DOI: 10.1111/bph.70198.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.